(NYSE: PBH) Prestige Consumer Healthcare's forecast annual revenue growth rate of 1.76% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 4.33%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.4%.
Prestige Consumer Healthcare's revenue in 2025 is $1,137,762,000.On average, 5 Wall Street analysts forecast PBH's revenue for 2026 to be $56,735,495,842, with the lowest PBH revenue forecast at $56,579,839,515, and the highest PBH revenue forecast at $57,024,571,878. On average, 5 Wall Street analysts forecast PBH's revenue for 2027 to be $57,820,543,978, with the lowest PBH revenue forecast at $57,518,718,948, and the highest PBH revenue forecast at $58,161,110,139.
In 2028, PBH is forecast to generate $59,402,407,579 in revenue, with the lowest revenue forecast at $59,396,477,814 and the highest revenue forecast at $59,408,337,344.